AstraZeneca Tests Diabetes Drug as COVID-19 Treatment in Phase 3 Trial

By Sam | April 23, 2020

AstraZeneca has begun a phase 3 clinical trial to evaluate its diabetes drug Farxiga (dapagliflozin) as a possible treatment for hospitalized COVID-19 patients.
Source: Drug Industry Daily

Posted in Drug Industry Daily